FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588230836> ?p ?o ?g. }

• W2588230836 endingPage "976" @default.
• W2588230836 startingPage "970" @default.
• W2588230836 abstract "Background and Purpose— This study was designed to evaluate the effectiveness and safety of rivaroxaban in real-world practice compared with effectiveness and safety of dabigatran or warfarin for stroke prevention in atrial fibrillation through meta-analyzing observational studies. Methods— Seventeen studies were included after searching in PubMed for studies reporting the comparative effectiveness and safety of rivaroxaban versus dabigatran (n=3), rivaroxaban versus Warfarin (n=11), or both (n=3) for stroke prevention in atrial fibrillation. Results— Overall, the risks of stroke/systematic thromboembolism with rivaroxaban were similar when compared with those with dabigatran (stroke/thromboembolism: hazard ratio, 1.02; 95% confidence interval, 0.91–1.13; I 2 =70.2%, N=5), but were significantly reduced when compared with those with warfarin (hazard ratio, 0.75; 95% confidence interval, 0.64–0.85; I 2 =45.1%, N=9). Major bleeding risk was significantly higher with rivaroxaban than with dabigatran (hazard ratio, 1.38; 95% confidence interval, 1.27–1.49; I 2 =26.1%, N=5), but similar to that with warfarin (hazard ratio, 0.99; 95% confidence interval, 0.91–1.07; I 2 =0.0%, N=6). Rivaroxaban was associated with increased all-cause mortality and gastrointestinal bleeding, but similar risk of acute myocardial infarction and intracranial hemorrhage when compared with dabigatran. When compared with warfarin, rivaroxaban was associated with similar risk of any bleeding, mortality, and acute myocardial infarction, but a higher risk of gastrointestinal bleeding and lower risk of intracranial hemorrhage. Conclusions— In this systematic review and meta-analysis, rivaroxaban was as effective as dabigatran, but was more effective than warfarin for the prevention of stroke/thromboembolism in atrial fibrillation patients. Major bleeding risk was significantly higher with rivaroxaban than with dabigatran, as was all-cause mortality and gastrointestinal bleeding. Rivaroxaban was comparable to warfarin for major bleeding, with an increased risk in gastrointestinal bleeding and decreased risk of intracranial hemorrhage." @default.
• W2588230836 created "2017-02-24" @default.
• W2588230836 creator A5038405190 @default.
• W2588230836 creator A5052183182 @default.
• W2588230836 creator A5075225035 @default.
• W2588230836 creator A5086025763 @default.
• W2588230836 date "2017-04-01" @default.
• W2588230836 modified "2023-10-17" @default.
• W2588230836 title "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation" @default.
• W2588230836 cites W1736100602 @default.
• W2588230836 cites W1964435302 @default.
• W2588230836 cites W1979423827 @default.
• W2588230836 cites W2007872832 @default.
• W2588230836 cites W2074206824 @default.
• W2588230836 cites W2080111455 @default.
• W2588230836 cites W2081134280 @default.
• W2588230836 cites W2097854437 @default.
• W2588230836 cites W2102255195 @default.
• W2588230836 cites W2111947972 @default.
• W2588230836 cites W2123251249 @default.
• W2588230836 cites W2125435699 @default.
• W2588230836 cites W2136489990 @default.
• W2588230836 cites W2143034000 @default.
• W2588230836 cites W2152623033 @default.
• W2588230836 cites W2157823046 @default.
• W2588230836 cites W2159530110 @default.
• W2588230836 cites W2314647904 @default.
• W2588230836 cites W2404409120 @default.
• W2588230836 cites W2433454023 @default.
• W2588230836 cites W2442037294 @default.
• W2588230836 cites W2513537003 @default.
• W2588230836 cites W2518330835 @default.
• W2588230836 cites W2518519006 @default.
• W2588230836 cites W2519736280 @default.
• W2588230836 cites W2520523056 @default.
• W2588230836 cites W2520573665 @default.
• W2588230836 cites W2521940263 @default.
• W2588230836 cites W2523719722 @default.
• W2588230836 cites W2527161344 @default.
• W2588230836 cites W2529460814 @default.
• W2588230836 cites W2531574476 @default.
• W2588230836 cites W2548706052 @default.
• W2588230836 doi "https://doi.org/10.1161/strokeaha.116.016275" @default.
• W2588230836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28213573" @default.
• W2588230836 hasPublicationYear "2017" @default.
• W2588230836 type Work @default.
• W2588230836 sameAs 2588230836 @default.
• W2588230836 citedByCount "89" @default.
• W2588230836 countsByYear W25882308362017 @default.
• W2588230836 countsByYear W25882308362018 @default.
• W2588230836 countsByYear W25882308362019 @default.
• W2588230836 countsByYear W25882308362020 @default.
• W2588230836 countsByYear W25882308362021 @default.
• W2588230836 countsByYear W25882308362022 @default.
• W2588230836 countsByYear W25882308362023 @default.
• W2588230836 crossrefType "journal-article" @default.
• W2588230836 hasAuthorship W2588230836A5038405190 @default.
• W2588230836 hasAuthorship W2588230836A5052183182 @default.
• W2588230836 hasAuthorship W2588230836A5075225035 @default.
• W2588230836 hasAuthorship W2588230836A5086025763 @default.
• W2588230836 hasBestOaLocation W25882308361 @default.
• W2588230836 hasConcept C126322002 @default.
• W2588230836 hasConcept C127413603 @default.
• W2588230836 hasConcept C164705383 @default.
• W2588230836 hasConcept C207103383 @default.
• W2588230836 hasConcept C2776301958 @default.
• W2588230836 hasConcept C2778080469 @default.
• W2588230836 hasConcept C2778661090 @default.
• W2588230836 hasConcept C2778810321 @default.
• W2588230836 hasConcept C2779161974 @default.
• W2588230836 hasConcept C2780645631 @default.
• W2588230836 hasConcept C42219234 @default.
• W2588230836 hasConcept C44249647 @default.
• W2588230836 hasConcept C500558357 @default.
• W2588230836 hasConcept C71924100 @default.
• W2588230836 hasConcept C78519656 @default.
• W2588230836 hasConceptScore W2588230836C126322002 @default.
• W2588230836 hasConceptScore W2588230836C127413603 @default.
• W2588230836 hasConceptScore W2588230836C164705383 @default.
• W2588230836 hasConceptScore W2588230836C207103383 @default.
• W2588230836 hasConceptScore W2588230836C2776301958 @default.
• W2588230836 hasConceptScore W2588230836C2778080469 @default.
• W2588230836 hasConceptScore W2588230836C2778661090 @default.
• W2588230836 hasConceptScore W2588230836C2778810321 @default.
• W2588230836 hasConceptScore W2588230836C2779161974 @default.
• W2588230836 hasConceptScore W2588230836C2780645631 @default.
• W2588230836 hasConceptScore W2588230836C42219234 @default.
• W2588230836 hasConceptScore W2588230836C44249647 @default.
• W2588230836 hasConceptScore W2588230836C500558357 @default.
• W2588230836 hasConceptScore W2588230836C71924100 @default.
• W2588230836 hasConceptScore W2588230836C78519656 @default.
• W2588230836 hasIssue "4" @default.
• W2588230836 hasLocation W25882308361 @default.
• W2588230836 hasLocation W25882308362 @default.
• W2588230836 hasOpenAccess W2588230836 @default.
• W2588230836 hasPrimaryLocation W25882308361 @default.
• W2588230836 hasRelatedWork W1972269502 @default.
• W2588230836 hasRelatedWork W2006773714 @default.

• next